Page 20 - ar2020-21
P. 20

• Hosted weekly (until March 2021) and bi-weekly (until May 2021) COVID-19 Healthcare-Associated Infections (HAI) Listening
                 Sessions with CDC’s Division of Healthcare Quality Promotion and CSTE’s HAI Subcommittee. After May, COVID-19 HAI topics
                 were rolled into the standing monthly HAI Subcommittee call series.
                  • Hosted biweekly COVID-19 Case Investigation and Contact Tracing (CI/CT) workgroup calls to discuss challenges and promising
                 practices, including metrics and indicators for measuring impact of CI/CT on disease transmission.
                  • Hosted several ad hoc webinars on topics such as: Exposure Notification Technology; Wastewater Surveillance; COVID-19 in
                 Pregnancy; and COVID-19 Whole Genome Sequencing Data Dashboards and Visualization.

              Partnerships

                  • Coordinated with APHL and CDC on electronic laboratory reporting topics, including meeting federal standards and requirements
                 for expanding lab reporting needs and solutions for onboarding, receiving, and managing increasing volumes of lab data.
                  • Coordinated with APHL to routinely release updated versions of
                 National Electronic Laboratory Reporting (ELR) Flat File and HL7
                 Generator Tool.
                  • Collaborated with ASTHO, NACCHO and APHL on mutual COVID-19
                 response priorities to streamline overall response coordination with
                 CDC’s IMS and other federal public health agencies.
                  • Collaborated with Linux Foundation Public Health and Resolve to Save   Approved
                 Lives to form a new working group focused on disease investigation
                 and outbreak response technology. Stakeholders and partners learn        revised COVID-19
                 from each other, share best practices and areas of improvement, and
                 help promote effective and sustainable CI/CT technologies.               standardized
                                                                                          surveillance position
              Resources
                                                                                          statement at the
                  • Approved final COVID-19 position statement (21-ID-01) in June 2021
                                                                                          2021 CSTE Business
                 and received CDC concurrence in July 2021.
                                                                                          Meeting

             20       Accomplishments
   15   16   17   18   19   20   21   22   23   24   25